| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bridging research and practice: enhancing regulatory decisions with pragmatic clinical trials in oncology
|
Stewart, M.D.
|
|
|
6 |
C |
p.
|
article
|
| 2 |
Cancer registry as external control data for regulatory submission in Japan
|
Bando, H.
|
|
|
6 |
C |
p.
|
article
|
| 3 |
Challenges and opportunities for real-world evidence in clinical oncology—a view from the UK: proceedings of a national workshop
|
Craddock, M.
|
|
|
6 |
C |
p.
|
article
|
| 4 |
Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours
|
Pellat, A.
|
|
|
6 |
C |
p.
|
article
|
| 5 |
Clinical trial and real-world evidence of circulating tumor DNA monitoring to predict recurrence in patients with resected colorectal cancer
|
Nguyen, H.T.
|
|
|
6 |
C |
p.
|
article
|
| 6 |
Comparative effectiveness among BRAF plus MEK inhibitors for patients with BRAF V600-mutant melanoma ☆
|
In, G.K.
|
|
|
6 |
C |
p.
|
article
|
| 7 |
EBANO study: real-world data from patients with locally advanced/metastatic urothelial carcinoma (la/mUC) in Northern Spain
|
Fernández Rodríguez, R.
|
|
|
6 |
C |
p.
|
article
|
| 8 |
Editoiral Board
|
|
|
|
6 |
C |
p.
|
article
|
| 9 |
Efficacy of cabozantinib and sunitinib for the treatment of intermediate/poor risk renal cell carcinoma based upon UK real-world data
|
Lee, D.
|
|
|
6 |
C |
p.
|
article
|
| 10 |
Human-centered AI as a framework guiding the development of image-based diagnostic tools in oncology: a systematic review
|
Allen, K.
|
|
|
6 |
C |
p.
|
article
|
| 11 |
Implementing digital patient-reported outcomes in routine cancer care: barriers and facilitators
|
Aanes, S.G.
|
|
|
6 |
C |
p.
|
article
|
| 12 |
Neoadjuvant compared to adjuvant chemotherapy combined with trastuzumab in patients with HER2-positive breast cancer: a register-based cohort study
|
Hosseini-Mellner, S.
|
|
|
6 |
C |
p.
|
article
|
| 13 |
Oncology education in the age of artificial intelligence
|
Prelaj, A.
|
|
|
6 |
C |
p.
|
article
|
| 14 |
Real-world evaluation of ImmuCare-PRO patient-reported outcomes in melanoma patients treated with immune checkpoint inhibitors
|
Belkaïd, S.
|
|
|
6 |
C |
p.
|
article
|
| 15 |
Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers
|
Pradervand, S.
|
|
|
6 |
C |
p.
|
article
|
| 16 |
Sequencing the anti-EGFR-TKIs; route to the longest survival
|
Güzel, H.G.
|
|
|
6 |
C |
p.
|
article
|
| 17 |
Superhuman performance on urology board questions using an explainable language model enhanced with European Association of Urology guidelines
|
Hetz, M.J.
|
|
|
6 |
C |
p.
|
article
|
| 18 |
Table of Contents
|
|
|
|
6 |
C |
p.
|
article
|
| 19 |
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
|
Rahmani Narj Abadi, K.
|
|
|
6 |
C |
p.
|
article
|
| 20 |
Using real world data to bridge the evidence gap left by prostate cancer screening trials
|
Norori, N.
|
|
|
6 |
C |
p.
|
article
|
Journal description